Pharmagro attended the TechBio conference held at Astra Zeneca’s headquarters in Cambridge. The theme of technological risk was strong. The Biotech Industries Association (BIA) report on “Functional Genomics” highlighted the increased understanding that genomics brings to biotech investing.
How we navigated compounding process changes, non-comparable proposals, and hidden CDMO risks.
In just four weeks we provided a strong analysis of CMC elements, embedded in financial, legal and operational issues.
We have made our Pharmagro Portfolio ManagementTool P2MT easier to use! In the Evaluation Section we have added templates. Use these to get started quickly on your evaluations.
See how Pharmagro could help your team structure the uncertainty, explore alternative scenarios and move toward a clearer decision.
